Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c (Q34600089)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c |
scientific article |
Statements
1 reference
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c (English)
1 reference
Eastern Cooperative Oncology Group
1 reference
Vernon K Sondak
1 reference
Michael B Atkins
1 reference
Jessie Hsu
1 reference
Sandra Lee
1 reference
Gary I Cohen
1 reference
Lawrence E Flaherty
1 reference
Jeffrey A Sosman
1 reference
John M Kirkwood
1 reference
10 November 2008
1 reference
1 reference
1 reference
Identifiers
1 reference